Kingworld Medicines Group Ltd. issued a supplemental announcement correcting a typographical error regarding the number of shares available for future grants under the 2025 Share Award Scheme. The corrected figure is 58,792,400 shares. The announcement also provided further information on the vesting period for awarded shares, highlighting that a shorter vesting period of less than 12 months from the grant date was deemed appropriate based on the grantees' performance and contributions.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kingworld Medicines Group Ltd. published the original content used to generate this news brief on July 10, 2025, and is solely responsible for the information contained therein.